Isoeugenol is a spice-like phenylpropanoid found at low levels in several floral and clove-associated aromatic materials, including ylang ylang and some clove leaf profiles in the AromaForge archive. The live literature is split between two very different bodies of evidence: preclinical studies on antimicrobial or oxidative-stress-related effects, and a much stronger safety and dermatology record showing that isoeugenol is a well-recognized skin sensitizer. For archive use, that means isoeugenol should be framed as a chemically interesting fragrance constituent with real laboratory bioactivity signals but a safety profile dominated by allergy risk rather than wellness claims.
Chemical identity and composition
PubChem identifies isoeugenol as C10H12O2 with InChIKey BJIOGJUNALELMI-ONEGZZNKSA-N and the E-configured IUPAC name 2-methoxy-4-[(E)-prop-1-enyl]phenol. In the local archive it appears directly in ylang ylang II at 0.5%, and a clove leaf redistilled record captures it below 0.10%, which fits its role as a low-level but allergen-relevant phenylpropanoid across several aromatic families.
Aroma and practical use
- Use the recorded spicy, clove-like, sweet, woody, warm descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2015 Frontiers in Microbiology study concluded that isoeugenol has a non-disruptive detergent-like mechanism of antibacterial action.
A 2015 Frontiers in Microbiology study concluded that isoeugenol has a non-disruptive detergent-like mechanism of antibacterial action.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2008 Journal of Applied Toxicology study reported that, in guinea pig maximization testing, isoeugenol was classified as an extreme sensitizer, while two isoeugenol dimers were weaker.
A 2008 Journal of Applied Toxicology study reported that, in guinea pig maximization testing, isoeugenol was classified as an extreme sensitizer, while two isoeugenol dimers were weaker.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 1996 Journal of Applied Toxicology study found positive contact-sensitization responses for both eugenol and isoeugenol in murine local lymph node and guinea pig maximization tests, with isoeugenol showing greater contact-sensitization potential.
A 1996 Journal of Applied Toxicology study found positive contact-sensitization responses for both eugenol and isoeugenol in murine local lymph node and guinea pig maximization tests, with isoeugenol showing greater contact-sensitization potential.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2013 Neurochemical Research study tested isoeugenol in an acrylamide-induced neuropathy rat model and reported behavioral and biochemical neuroprotective effects, but this remains animal-only evidence outside fragrance use context.
A 2013 Neurochemical Research study tested isoeugenol in an acrylamide-induced neuropathy rat model and reported behavioral and biochemical neuroprotective effects, but this remains animal-only evidence outside fragrance use context.
This experimental finding does not establish benefit, dose or safety in people using this blend.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
recorded reference · IFRA Standard, Isoeugenol (CAS 97-54-1), Amendment 49 (2020) - Category 11A/11B (leave-on non-skin-contact-excluded categories) maximum acceptable concentration in finished product: 0.0090%ECHA's harmonized classification page for isoeugenol lists Skin Sens. 1A with hazard statement H317, supporting a strong fragrance-allergen framing.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
A dermatology review summarizing repeated open application testing reports that 63 ppm in deodorants triggered allergic reactions in 3 of 13 isoeugenol-sensitized patients, with low microgram-per-square-centimeter elicitation thresholds in hydroalcoholic bases.
Apply this finding only to the studied preparation, participants, route and outcome. It does not establish the same result for a custom oil blend.
No direct public citation is attached to this entry.
Because the most accessible efficacy findings are in vitro or animal studies and the strongest human data concern contact allergy, archive copy should avoid health claims and foreground sensitization risk.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
These are research candidates recorded in the interaction matrix. They do not add a proven-amplification bonus to the score.
EugenolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Eugenol report →How the effects were investigated
non disruptive detergent like antibacterial action
A 2015 Frontiers in Microbiology paper reported that isoeugenol showed a non-disruptive detergent-like antibacterial mechanism of action rather than simple catastrophic membrane rupture.
This experimental finding does not establish benefit, dose or safety in people using this blend.
No direct public citation is attached to this entry.
contact sensitization potency
Animal sensitization studies and clinical allergy literature consistently place isoeugenol as a stronger skin sensitizer than eugenol, aligning with its regulatory allergen status.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- No human clinical efficacy study specific to isolated isoeugenol was verified in this pass.
- The public evidence base is stronger for contact allergy and hazard classification than for beneficial use claims.
- Occurrence in archive oils is documented, but composition ranges across botanical sources likely vary more than the accessible examples here capture.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.
- Interaction candidates lack an attached source citation and remain unqualified.